We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Proteome Sciences Plc | PRM | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.05 | 1.47% | 3.45 | 16:35:23 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.45 | 3.40 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 16/5/2024 11:46 by jeffian There's a presentation on the Investormeet website at 12.00 if you're interested GRC. |
Posted at 11/5/2024 16:16 by base7 Interesting to note that there will be an Investor Meets next Thursday @ midday.These presentations usually take place within a day or two of results or following significant contract news.It will be 3 weeks after the recent RNS regarding the 500k contract, which I would not have thought would warrant a CEO presentation -so what might our CEO have to tell us next Thursday which we dont already know following results last month & the recent contract award ? The optimist in me hopes for an RNS ahead of Thursdays presentation which will explain clearly why our CEO considers it necessary to make a presentation. |
Posted at 01/5/2024 07:30 by pools2 I'm not sure investors fully appreciate the significance of Proteome Sciences new 32-plex TMTpro reagents, which will probably be officially announced by Thermo at this years ASMS in Anaheim early next month. It's not just a near doubling of the current 18-plex TMTpro reagent, but also a massive improvement of Thermo's mass spec capabilities, which will leave their competitors far behind them in performance and sample throughput.One users perspective :- www.proteomicsnews.b The new 32-plex TMTpro reagents will have big consequences for the mass spec proteomics market and its competitors. |
Posted at 10/4/2024 10:02 by pools2 wasjobber,Thermo have been a long term partner of Proteome Sciences for 15 years, but I agree it'll be good to see Thermo taking a more prominent position. After reading the RNS this morning, the future looks brighter than ever. You've already mentioned what I think is probably the most significant RNS statement:- "It's very interesting that PRM are now openly stating that their patented Alzheimer's and cancer biomarkers may be critical to new diagnostics and treatment moving forward. STRONG BUY" It's very significant for Proteome Sciences to say that. The value of these biomarkers will be considerable and will project PRM into the £100 millions plus market cap. with ease. I think you are now correct, we are at a pivotal moment for the share price and investors buying now will achieve significant returns, possibly quicker than some may think. |
Posted at 08/4/2024 11:19 by wasjobber The trades look like Bed & ISA's to start the new tax year.Definitely some type of 'put through' and completely market neutral. It's a sign of confidence from investors. |
Posted at 28/3/2024 11:39 by dominiccummings #92819 Even the most experienced investors have been 'taken' by this company. |
Posted at 14/2/2024 19:59 by peverill Does Richard not remember he sold out a few years ago,bought back in near 6p ish and now claiming he made a significant profit when the share price has been in the doldrums for the last 5 years.Even with dynamic Mrs S at the helm being unable to budge the price despite picking up over a million in wages and taking the company back 10 years and putting numerous investors on the breadline. |
Posted at 14/2/2024 14:05 by elpirata good post pevpeverill 14 Feb '24 - 13:28 - 92720 of 92720 0 1 0 Nobody hates PRM,the problem lies with the total lack of movement in the 25 years they have been on the go,30 plus years counting electrophoretics.The |
Posted at 14/2/2024 13:28 by peverill Nobody hates PRM,the problem lies with the total lack of movement in the 25 years they have been on the go,30 plus years counting electrophoretics.The |
Posted at 07/2/2024 10:42 by monte1 Quite, I wonder how well that strategy has worked out for previous investors*?*suckers |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
